{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:14:49Z","timestamp":1790806489173,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024603","name":"Blue Earth Diagnostics Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024603","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ijrobp.2026.02.239","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T08:06:42Z","timestamp":1772093202000},"page":"1410-1420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["18F-Fluciclovine for Detection of Recurrent Brain Metastases After Radiation Therapy: Image Interpretation Criteria and Diagnostic Performance From the PURSUE Study"],"prefix":"10.1016","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6927-0402","authenticated-orcid":false,"given":"Rupesh","family":"Kotecha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin C.","family":"Tom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ephraim","family":"Parent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Nabavizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry A.","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elcin","family":"Zan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Peddi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Brem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Ware","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik P.","family":"Sulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Kesari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitney","family":"Pope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Chau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene J.","family":"Teoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel T.","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Aboian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa","family":"Barbaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surya","family":"Chundru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Fogelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manu S.","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Kondziolka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goldie","family":"Kurtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Lokuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minesh P.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazmin","family":"Odia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosana","family":"Ponisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Weick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2026.02.239_bib0001","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s43856-024-00445-7","article-title":"Estimating the risk of brain metastasis for patients newly diagnosed with cancer","volume":"4","author":"Miccio","year":"2024","journal-title":"Commun Med (Lond)"},{"key":"10.1016\/j.ijrobp.2026.02.239_bib0002","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41571-019-0320-3","article-title":"Current approaches to the management of brain metastases","volume":"17","author":"Suh","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.239_bib0003","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1200\/JCO.21.02314","article-title":"Treatment for brain metastases: ASCO-SNO-ASTRO guideline","volume":"40","author":"Vogelbaum","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.239_bib0004","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.annonc.2021.07.016","article-title":"EANO-ESMO clinical practice guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours","volume":"32","author":"Le Rhun","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.239_bib0005","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/neuonc\/noz003","article-title":"PET imaging in patients with brain metastasis-report of the RANO\/PET group","volume":"21","author":"Galldiks","year":"2019","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.239_bib0006","unstructured":"NCCN. NCCN clinical practice guidelines in oncology: Central nervous system cancers. Version 1.2025. Accessed October 23, 2025 https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cns.pdf"},{"key":"10.1016\/j.ijrobp.2026.02.239_bib0007","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11060-012-0881-9","article-title":"Conventional MRI does not reliably distinguish radiation necrosis from tumor recurrence after stereotactic radiosurgery","volume":"109","author":"Stockham","year":"2012","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2026.02.239_bib0008","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.ijrobp.2018.05.041","article-title":"Distinguishing true progression from radionecrosis after stereotactic radiation therapy for brain metastases with machine learning and radiomics","volume":"102","author":"Peng","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.02.239_bib0009","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s11060-024-04578-6","article-title":"Adverse radiation effect versus tumor progression following stereotactic radiosurgery for brain metastases: Implications of radiologic uncertainty","volume":"166","author":"Salans","year":"2024","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2026.02.239_bib0010","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3389\/fonc.2019.00440","article-title":"Advanced magnetic resonance imaging techniques in management of brain metastases","volume":"9","author":"Mehrabian","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.239_bib0011","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fneur.2016.00120","article-title":"Amino acid PET - An imaging option to identify treatment response, posttherapeutic effects, and tumor recurrence?","volume":"7","author":"Galldiks","year":"2016","journal-title":"Front Neurol"},{"key":"10.1016\/j.ijrobp.2026.02.239_bib0012","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s11060-023-04377-5","article-title":"18F-fluciclovine PET\/CT to distinguish radiation necrosis from tumor progression for brain metastases treated with radiosurgery: Results of a prospective pilot study","volume":"163","author":"Tom","year":"2023","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2026.02.239_bib0013","doi-asserted-by":"crossref","first-page":"8874078","DOI":"10.1155\/2021\/8874078","article-title":"Comparison of amino acid PET to advanced and emerging MRI techniques for neurooncology imaging: A systematic review of the recent studies","volume":"2021","author":"Stopa","year":"2021","journal-title":"Mol Imaging"},{"key":"10.1016\/j.ijrobp.2026.02.239_bib0014","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00259-019-04433-1","article-title":"18F-fluciclovine (18F-FACBC) PET imaging of recurrent brain tumors","volume":"47","author":"Michaud","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2026.02.239_bib0015","first-page":"85","article-title":"Diagnosis of brain tumors using amino acid transport PET imaging with 18F-fluciclovine: A comparative study with L-methyl-11C-methionine PET imaging","volume":"5","author":"Tsuyuguchi","year":"2017","journal-title":"Asia Oceania J Nucl Med Biol"},{"key":"10.1016\/j.ijrobp.2026.02.239_bib0016","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s00259-022-06040-z","article-title":"Glioblastoma PET\/MRI: Kinetic investigation of [18F]rhPSMA-7.3, [18F]FET and [18F]fluciclovine in an orthotopic mouse model of cancer","volume":"50","author":"Lindemann","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2026.02.239_bib0017","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/neuonc\/noaa030","article-title":"Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases","volume":"22","author":"Kaufmann","year":"2020","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.239_bib0018","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","article-title":"From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors","volume":"50","author":"Wahl","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2026.02.239_bib0019","series-title":"Common terminology criteria for adverse events (CTCAE). Version 5.0","year":"2017"},{"key":"10.1016\/j.ijrobp.2026.02.239_bib0020","first-page":"152","article-title":"18F-fluciclovine PET to distinguish treatment-related effects from disease progression in recurrent glioblastoma: PET fusion with MRI guides neurosurgical sampling","volume":"7","author":"Henderson F","year":"2020","journal-title":"Neurooncol Pract"},{"key":"10.1016\/j.ijrobp.2026.02.239_bib0021","doi-asserted-by":"crossref","first-page":"852","DOI":"10.2967\/jnumed.122.264812","article-title":"Distinguishing progression from pseudoprogression in glioblastoma using 18F-fluciclovine PET","volume":"64","author":"Nabavizadeh","year":"2023","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2026.02.239_bib0022","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s12149-021-01670-z","article-title":"Determining the extent of tumor resection at surgical planning with 18F-fluciclovine PET\/CT in patients with suspected glioma: Multicenter phase III trials","volume":"35","author":"Wakabayashi","year":"2021","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.ijrobp.2026.02.239_bib0023","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.juro.2016.09.117","article-title":"Multisite experience of the safety, detection rate and diagnostic performance of fluciclovine (18F) positron emission tomography\/computerized tomography imaging in the staging of biochemically recurrent prostate cancer","volume":"197","author":"Bach-Gansmo","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2026.02.239_bib0024","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.3174\/ajnr.A2668","article-title":"A comprehensive review of MR imaging changes following radiosurgery to 500 brain metastases","volume":"32","author":"Patel","year":"2011","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.ijrobp.2026.02.239_bib0025","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijrobp.2023.07.015","article-title":"A systematic review informing the management of symptomatic brain radiation necrosis after stereotactic radiosurgery and international stereotactic radiosurgery society recommendations","volume":"118","author":"Vellayappan","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.02.239_bib0026","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.brainres.2013.08.037","article-title":"Comparative evaluation of transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid and L-[methyl-11C]methionine in human glioma cell lines","volume":"1535","author":"Ono","year":"2013","journal-title":"Brain Res"},{"key":"10.1016\/j.ijrobp.2026.02.239_bib0027","series-title":"Highlights of prescribing information: AXUMIN (fluciclovine F 18) injection","year":"2016"},{"key":"10.1016\/j.ijrobp.2026.02.239_bib0028","doi-asserted-by":"crossref","first-page":"822","DOI":"10.2967\/jnumed.110.086074","article-title":"Putative transport mechanism and intracellular fate of trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid in human prostate cancer","volume":"52","author":"Okudaira","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2026.02.239_bib0029","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s00259-012-2291-9","article-title":"Regional distribution and kinetics of [18F]fluciclovine (anti-[18F]FACBC), a tracer of amino acid transport, in subjects with primary prostate cancer","volume":"40","author":"Sorensen","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2026.02.239_bib0030","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1053\/j.sult.2010.10.001","article-title":"Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy","volume":"31","author":"Kinahan","year":"2010","journal-title":"Semin Ultrasound CT MR"},{"key":"10.1016\/j.ijrobp.2026.02.239_bib0031","first-page":"1519","article-title":"Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: A simulation study","volume":"45","author":"Boellaard","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2026.02.239_bib0032","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1593\/tlo.13850","article-title":"Biases in multicenter longitudinal PET standardized uptake value measurements","volume":"7","author":"Doot","year":"2014","journal-title":"Transl Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.239_bib0033","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2214\/AJR.10.4923","article-title":"A systematic review of the factors affecting accuracy of SUV measurements","volume":"195","author":"Adams","year":"2010","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ijrobp.2026.02.239_bib0034","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1007\/s00259-024-07038-5","article-title":"Joint EANM\/EANO\/RANO\/SNMMI practice guideline\/procedure standard for PET imaging of brain metastases: version 1.0","volume":"52","author":"Verger","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2026.02.239_bib0035","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.radonc.2022.10.026","article-title":"Diagnostic accuracy of MRI techniques for treatment response evaluation in patients with brain metastasis: A systematic review and meta-analysis","volume":"177","author":"Teunissen","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.239_bib0036","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3174\/ajnr.A6384","article-title":"Effects of susceptibility artifacts on perfusion MRI in patients with primary brain tumor: A comparison of arterial spin-labeling versus DSC","volume":"41","author":"Maral","year":"2020","journal-title":"AJNR Am J Neuroradiol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626004311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626004311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T08:25:28Z","timestamp":1784276728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301626004311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0360301626004311"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.02.239","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"18F-Fluciclovine for Detection of Recurrent Brain Metastases After Radiation Therapy: Image Interpretation Criteria and Diagnostic Performance From the PURSUE Study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.02.239","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}